Health Condition 1: M754- Impingement syndrome of shoulder
Conditions
Interventions
Intervention1: USG guided Platelet rich plasma injection: For ultrasound guided platelet rich plasma injection, the patient will be placed in lateral lying position and the procedure will be performed
Sponsors
Guru Teg bahadur Hospital, University of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients having clinically diagnosed/suspected shoulder pathologies with refractory/recurrent pain and functional deficit for more than 2 months not resolving with conservative treatments i.e. NSAIDs and physiotherapy.
Exclusion criteria
Exclusion criteria: • Pregnant patients • Patients having other causes of shoulder pain such as adhesive capsulitis, full thickness rotator cuff tears, major trauma, recurrent dislocations, osteoarthritis, inflammatory joint disease, cervical radiculopathy, thoracic outlet syndrome and bone tumors/ other malignancy at shoulder joint. • Patients already diagnosed with neuromuscular disease or muscle disease. • Patients with underlying coagulopathies, thrombocytopenia or taking anti-coagulant medications or having pace-maker. • Patients with local site infection or localised dermatological condition. • Patients who have recieved prior corticosteroid injection or have taken NSAIDs in last week(relative contra-indication). • Patients who have undergone arthroscopic or open surgery of the affected shoulder, back or neck or have metallic implants in situ in the affected shoulder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change from baseline of severity of symptoms and functional status using QDASH questionnaire in the two groups. 2. Change from baseline of pain using Visual Analogue Scale (VAS) in the two groups. 3. Change from baseline of range of movements using goniometer in the two groups. 4. Comparison of the improvement between the two groups.Timepoint: Evaluation will be done at baseline, 6 weeks and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Comparison of improvement of quality of life after the completion of the treatment in both groups using WORC. 2. To document any change in USG appearances/findings in the two groups, if any.Timepoint: Evaluation will be done at baseline, 6 weeks & 12 weeks | — |
Countries
India
Contacts
Public ContactRohit Krishna Dev
Guru Teg Bahadur hospital, University of medical sciences, new delhi
Outcome results
None listed